Asa Abeliovich, founder of Prevail and Alector, and now Leal Therapeutics

Scoop: Star neu­ro­sci­en­tist Asa Abe­liovich and Or­biMed are team­ing on yet an­oth­er biotech

It’s been bare­ly a year since Eli Lil­ly bought his sec­ond com­pa­ny, Pre­vail Ther­a­peu­tics, for $1 bil­lion, but star Co­lum­bia neu­ro­sci­en­tist Asa Abe­liovich is al­ready launch­ing some­thing new.

Two jobs were post­ed on LinkedIn last week for Leal Ther­a­peu­tics, each re­cruit­ing sci­en­tists to a “CNS-fo­cused biotech start-up work­ing to de­vel­op a pipeline of nov­el, ul­tra-pre­cise ther­a­peu­tics for ma­jor CNS in­di­ca­tions with ur­gent un­met needs.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA